Search
Patexia Research
Case number 2:18-cv-16521

BTG INTERNATIONAL LIMITED et al v. QILU PHARMACEUTICAL CO., LTD. et al > Documents

Date Field Doc. No.Description (Pages)
May 28, 2019 12 Order of Dismissal (1)
Docket Text: PLAINTIFF'S NOTICE AND ORDER OF VOLUNTARY DISMISSAL; Pursuant to Federal Rule of Civil Procedure 41(a)(I)(A)(i), Plaintiffs BTG International Limited. Janssen Biotech. Inc., Janssen Oncology, Inc.. and Janssen Research & Development. LLC, by and through their undersigned counsel, hereby voluntarily dismiss this action without prejudice. No defendant has served an answer or a motion for summary judgment. Signed by Judge Kevin McNulty on 5/28/2019. (sms)
May 24, 2019 11 Notice of Voluntary Dismissal (aty) (2)
Docket Text: NOTICE of Voluntary Dismissal by All Plaintiffs (MILLER, KEITH)
May 8, 2019 10 Order (2)
Docket Text: CONSENT ORDER EXTENDING TIME TO ANSWER, MOVE OR OTHERWISE RESPOND TO THE COMPLAINT; The Defendants' time to answer, move or otherwise respond to the Complaint be and hereby is extended to and including June 7, 2019. Signed by Magistrate Judge James B. Clark on 5/7/2019. (sms)
May 7, 2019 9 Letter (1)
May 7, 2019 9 Text of Proposed Order (2)
May 7, 2019 9 Main Document (1)
Docket Text: Letter from Keith J. Miller, Esq. to Hon. James Clark, USMJ. (Attachments: # (1) Text of Proposed Order)(MILLER, KEITH)
Apr 5, 2019 8 Letter (1)
Apr 5, 2019 8 Text of Proposed Order (2)
Apr 5, 2019 8 Main Document (1)
Docket Text: Letter from Keith Miller to Judge Clark enclosing proposed Consent Order extending time. (Attachments: # (1) Text of Proposed Order)(MILLER, KEITH)
Feb 14, 2019 6 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by JANSSEN RESEARCH & DEVELOPMENT, L.L.C., BTG INTERNATIONAL LIMITED, JANSSEN ONCOLOGY, INC., JANSSEN BIOTECH, INC.. QILU PHARMA, INC. waiver sent on 2/7/2019, answer due 4/8/2019. (MILLER, KEITH)
Feb 14, 2019 7 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by JANSSEN RESEARCH & DEVELOPMENT, L.L.C., BTG INTERNATIONAL LIMITED, JANSSEN ONCOLOGY, INC., JANSSEN BIOTECH, INC.. QILU PHARMACEUTICAL CO., LTD. waiver sent on 2/7/2019, answer due 4/8/2019. (MILLER, KEITH)
Nov 30, 2018 5 AO120 Patent/Trademark Form (1)
Nov 30, 2018 4 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to QILU PHARMA, INC., QILU PHARMACEUTICAL CO., LTD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (sms)
Nov 30, 2018 5 Complaint (21)
Nov 30, 2018 5 Exhibit A (13)
Nov 30, 2018 5 Exhibit B (3)
Nov 30, 2018 5 Main Document (1)
Docket Text: AO120 Patent/Trademark Form filed. (sms) (Additional attachment(s) added on 11/30/2018: # (1) Complaint, # (2) Exhibit A, # (3) Exhibit B) (sms, ).
Nov 29, 2018 2 Corporate Disclosure Statement (aty) (3)
Docket Text: Corporate Disclosure Statement by BTG INTERNATIONAL LIMITED identifying BTG plc as Corporate Parent.. (MILLER, KEITH)
Nov 29, 2018 3 Corporate Disclosure Statement (aty) (3)
Docket Text: Corporate Disclosure Statement by JANSSEN BIOTECH, INC., JANSSEN ONCOLOGY, INC., JANSSEN RESEARCH & DEVELOPMENT, L.L.C. identifying Johnson & Johnson as Corporate Parent.. (MILLER, KEITH)
Nov 28, 2018 1 Complaint (21)
Nov 28, 2018 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Kevin McNulty and Magistrate Judge James B. Clark. (ak, )
Nov 28, 2018 1 Exhibit A to Complaint (13)
Nov 28, 2018 1 Exhibit B to Complaint (3)
Nov 28, 2018 1 Civil Cover Sheet (1)
Nov 28, 2018 1 Main Document (21)
Docket Text: COMPLAINT against All Defendants ( Filing and Admin fee $ 400 receipt number 0312-9200711), filed by JANSSEN RESEARCH & DEVELOPMENT, L.L.C., BTG INTERNATIONAL LIMITED, JANSSEN ONCOLOGY, INC., JANSSEN BIOTECH, INC.. (Attachments: # (1) Exhibit A to Complaint, # (2) Exhibit B to Complaint, # (3) Civil Cover Sheet)(MILLER, KEITH)
Nov 28, 2018 1 Complaint* (1)
Menu